~~<i id='46C50691C4'><strike id='46C50691C4'><tt id='46C50691C4'><pre id='46C50691C4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：fashion 2025-09-02 08:11:43 - browse：531

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Americans' trust in science, scientist continues decline: Report

explore

Wikipedia

knowledge

entertainment

hotspot

AdobeNearlyadecadeago,consultantsdeliveredtoRodgerNovakakindofSearscatalogofhumanmalady:200pages,lis

WSS

SCOTUS to consider access to abortion pill mifepristone

STAT letters to the editor on burnt

What causes an itch? Researchers may have solved the mystery

Timeline: Key moments in fight for gay rights

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

FDA approves world's first CRISPR

focus

hotspot

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Bispecific antibodies are next new thing in cancer immunotherapy

BioMarin wins approval for gene therapy to treat hemophilia A

Altering the blood type of lungs raises potential for universal organs for transplants

Heart attack and stroke risk calculators need revising

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Pfizer plans to depart BIO

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

AI models in health care face new federal disclosure requirements

explore

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Supreme Court wrestles with OxyContin maker's bankruptcy deal

FDA approves first new drug developed for postpartum depression

After sickle

Timeline: Key moments in fight for gay rights

Wikipedia

knowledge

entertainment

hotspot